167 related articles for article (PubMed ID: 19362880)
41. [Cutaneous drug eruption with two antihistaminic drugs of a same chemical family: cetirizine and hydroxyzine].
Assouère MN; Mazereeuw-Hautier J; Bonafé JL
Ann Dermatol Venereol; 2002 Nov; 129(11):1295-8. PubMed ID: 12514519
[TBL] [Abstract][Full Text] [Related]
42. Electromyographic mixed nerve and cutaneous silent period in evaluating the A-delta fibres in a patient with hereditary sensory-autonomic neuropathy.
Corsi FM; Fausti S; Serrao M; Casali C; Parisi L; Piazza G
Funct Neurol; 2002; 17(1):31-4. PubMed ID: 12086110
[TBL] [Abstract][Full Text] [Related]
43. Normal motor nerve conduction studies using surface electrode recording from the supraspinatus, infraspinatus, deltoid, and biceps.
Buschbacher RM; Weir SK; Bentley JG; Cottrell E
PM R; 2009 Feb; 1(2):101-6. PubMed ID: 19627883
[TBL] [Abstract][Full Text] [Related]
44. Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
Elzainy AA; Gu X; Simons FE; Simons KJ
AAPS J; 2004 Aug; 6(3):e18. PubMed ID: 15760103
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous silent period in hand muscles is lengthened by tramadol: Evidence for monoaminergic modulation?
Pujia F; Coppola G; Anastasio MG; Brienza M; Vestrini E; Valente GO; Parisi L; Serrao M; Pierelli F
Neurosci Lett; 2012 Oct; 528(1):78-82. PubMed ID: 22981885
[TBL] [Abstract][Full Text] [Related]
46. Effects of a selective serotonin reuptake inhibitor escitalopram on the cutaneous silent period: a randomized controlled study in healthy volunteers.
Pujia F; Serrao M; Brienza M; Vestrini E; Valente GO; Coppola G; Pierelli F
Neurosci Lett; 2014 Apr; 566():17-20. PubMed ID: 24589881
[TBL] [Abstract][Full Text] [Related]
47. Tonic central and sensory stimuli facilitate involuntary air-stepping in humans.
Selionov VA; Ivanenko YP; Solopova IA; Gurfinkel VS
J Neurophysiol; 2009 Jun; 101(6):2847-58. PubMed ID: 19339461
[TBL] [Abstract][Full Text] [Related]
48. Cutaneous silent period in patients with spinal muscular atrophy type 2 and type 3.
Gunduz A; Kofler M; Aktan Suzgun M; Tutuncu M; Karaali-Savrun F; Uzun N; E Kızıltan M
Neurophysiol Clin; 2020 Oct; 50(5):353-359. PubMed ID: 32951956
[TBL] [Abstract][Full Text] [Related]
49. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.
Cravo M; Gonçalo M; Figueiredo A
Int J Dermatol; 2007 Jul; 46(7):760-2. PubMed ID: 17614812
[TBL] [Abstract][Full Text] [Related]
50. Modulation of exteroceptive electromyographic responses in defensive peripersonal space.
Versace V; Campostrini S; Sebastianelli L; Saltuari L; Kofler M
J Neurophysiol; 2019 Apr; 121(4):1111-1124. PubMed ID: 30811266
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory effect of the Jendrassik maneuver on the stretch reflex.
Nardone A; Schieppati M
Neuroscience; 2008 Oct; 156(3):607-17. PubMed ID: 18713647
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous silent period (CSP) in peripheral neuropathies represents the temporary suppression of the intentional electromyographic activities.
Francia A; Restante R; Mistura L; Fabri P; Mamarella A; Pennisi E; Manfredi M
J Peripher Nerv Syst; 1999; 4(1):86. PubMed ID: 10197067
[No Abstract] [Full Text] [Related]
53. Evaluation of the Cutaneous Silent Period in a Healthy Brazilian Population.
Cunha NSC; Grippe T; Boechat-Barros R; Fernandez RNM; Brandão PRP; Chen R; Cardoso F
J Clin Neurophysiol; 2023 Sep; 40(6):541-546. PubMed ID: 35349508
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
55. The cutaneous silent period is preserved in cervical radiculopathy: significance for the diagnosis of cervical myelopathy.
Leis AA; Kofler M; Stetkarova I; Stokic DS
Eur Spine J; 2011 Feb; 20(2):236-9. PubMed ID: 21132557
[TBL] [Abstract][Full Text] [Related]
56. Experimental study of a late response recorded from the thoracic wall after phrenic nerve stimulation.
Rouaud T; Magot A; Guihéneuc P; Perrouin Verbe B; Truffert A; Péréon Y
Clin Neurophysiol; 2009 Aug; 120(8):1543-7. PubMed ID: 19577512
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous antihistaminic action of cetirizine and dose-related EEG concomitants of sedation in man.
Sannita WG; Crimi E; Riela S; Rosadini G; Brusasco V
Eur J Pharmacol; 1996 Apr; 300(1-2):33-41. PubMed ID: 8741162
[TBL] [Abstract][Full Text] [Related]
58. The effects of age, gender, and body mass index on amplitude of sensory nerve action potentials: multivariate analyses.
Fujimaki Y; Kuwabara S; Sato Y; Isose S; Shibuya K; Sekiguchi Y; Nasu S; Noto Y; Taniguchi J; Misawa S
Clin Neurophysiol; 2009 Sep; 120(9):1683-6. PubMed ID: 19640782
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous silent periods - Part 1: Update on physiological mechanisms.
Kofler M; Leis AA; Valls-Solé J
Clin Neurophysiol; 2019 Apr; 130(4):588-603. PubMed ID: 30691969
[TBL] [Abstract][Full Text] [Related]
60. Reproducibility in nerve conduction studies and F-wave analysis.
Pinheiro DS; Manzano GM; Nóbrega JA
Clin Neurophysiol; 2008 Sep; 119(9):2070-3. PubMed ID: 18621579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
